A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations.
Moon Ki Choi
No relevant relationships to disclose
Jung Yong Hong
No relevant relationships to disclose
Won Jin Chang
No relevant relationships to disclose
Moonjin Kim
No relevant relationships to disclose
Sungmin Kim
No relevant relationships to disclose
Hyun Ae Jung
No relevant relationships to disclose
Sung Hee Lim
No relevant relationships to disclose
Ji Yun Lee
No relevant relationships to disclose
Ingu Do
No relevant relationships to disclose
Yoon-La Choi
No relevant relationships to disclose
Jong-Mu Sun
No relevant relationships to disclose
Jin Seok Ahn
No relevant relationships to disclose
Keunchil Park
No relevant relationships to disclose
Myung-Ju Ahn
No relevant relationships to disclose